Keywords: Bayer, Evotec, Endometriosis collaboration, Clinical candidates

Bayer inks up to 592 million-euro endometriosis deal with Evotec

Article | 02 October 2012

Print This

Drug major Bayer (BAYN: DE) and fellow German company Evotec (EVT: TecDAX) have entered into a five-year, multi-target collaboration with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in